Hormonal regulation of placental nitric oxide and pathogenesis of pre-eclampsia

Trends in Molecular Medicine

Volumn 12, Issue 5, 2006, Pages 223-233

  Vatish, Manu ^a   Randeva, Harpal S ^a   Grammatopoulos, Dimitris K ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACENTA PROTEIN;

BLOOD VESSEL TONE; FETUS DEVELOPMENT; FETUS GROWTH; HORMONAL REGULATION; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLACENTA FUNCTION; PREECLAMPSIA; PREGNANCY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; FEMALE; HORMONES; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

MAMMALIA;

EID: 33646557966     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.03.003     Document Type: Review

References (95)

1. Mossman H.W. Classics revisited: comparative morphogenesis of the fetal membranes and accessory uterine structures. Placenta 12 (1991) 1-5
2. Petraglia F., et al. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr. Rev. 17 (1996) 156-186
3. Reynolds L.P., and Redmer D.A. Utero-placental vascular development and placental function. J. Anim. Sci. 73 (1995) 1839-1851
4. Block B.S., et al. Intrauterine growth retardation and the circulatory responses to acute hypoxemia in fetal sheep. Am. J. Obstet. Gynecol. 161 (1989) 1576-1579
5. Block B.S., et al. Regional blood flow distribution in fetal sheep with intrauterine growth retardation produced by decreased umbilical placental perfusion. J. Dev. Physiol. 13 (1990) 81-85
6. Meegdes B.H., et al. Early pregnancy wastage: relationship between chorionic vascularization and embryonic development. Fertil. Steril. 49 (1988) 216-220
7. Kokawa K., et al. Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta 19 (1998) 21-26
8. Trudinger B.J., et al. Uteroplacental blood flow velocity-time waveforms in normal and complicated pregnancy. Br. J. Obstet. Gynaecol. 92 (1985) 39-45
9. Kotini A., et al. Correlation between biomagnetic and Doppler findings of umbilical artery in fetal growth restriction. Prenat. Diagn. 23 (2003) 325-330
10. Clark P.M. Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis. Eur. J. Pediatr. 157 Suppl. 1 (1998) S7-S10
11. Smith G.C., et al. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357 (2001) 2002-2006
12. Seely E.W., and Solomon C.G. Insulin resistance and its potential role in pregnancy-induced hypertension. J. Clin. Endocrinol. Metab. 88 (2003) 2393-2398
13. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
14. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of preeclampsia. Lancet 357 (2001) 53-56
15. Szulman A.E., and Surti U. The clinicopathologic profile of the partial hydatidiform mole. Obstet. Gynecol. 59 (1982) 597-602
16. Granger J.P., et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9 (2002) 147-160
17. Carlson, B.M. (1994) In Human embryology and developmental biology. (St. Louis: Mosby-Year Book ed.) pp. 87-107
18. Reynolds L.P., and Redmer D.A. Angiogenesis in the placenta. Biol. Reprod. 64 (2001) 1033-1040
19. Bischof P., et al. Biochemistry and molecular biology of trophoblast invasion. Ann. N. Y. Acad. Sci. 943 (2001) 157-162
20. Burton G., et al. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Am. J. Obstet. Gynecol. 181 (1999) 718-724
21. Meekins J.W., et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 101 (1994) 669-674
22. Forstermann U., et al. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol. 42 (1991) 1849-1857
23. Buttery L.D., et al. Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto-maternal interface. Placenta 15 (1994) 257-265
24. Zarlingo T.J., et al. Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae. Placenta 18 (1997) 511-520
25. Takizawa T., et al. Expression of nitric oxide synthase isoforms and detection of nitric oxide in rat placenta. Am. J. Physiol. Cell Physiol. 282 (2002) C762-C767
26. Chwalisz K., and Garfield R.E. Role of nitric oxide in implantation and menstruation. Hum. Reprod. 15 Suppl 3 (2000) 96-111
27. Chwalisz K., and Garfield R.E. Role of nitric oxide in the uterus and cervix: implications for the management of labor. J. Perinat. Med. 26 (1998) 448-457
28. Buxton I.L. Regulation of uterine function: a biochemical conundrum in the regulation of smooth muscle relaxation. Mol. Pharmacol. 65 (2004) 1051-1059
29. Tichenor S.D., et al. Dissociation of cGMP accumulation and relaxation in myometrial smooth muscle: effects of S-nitroso-N-acetylpenicillamine and 3-morpholinosyndonimine. Cell. Signal. 15 (2003) 763-772
30. Roh C.R., et al. Regulation of connexin-43 by nitric oxide in primary uterine myocytes from term pregnant women. Am. J. Obstet. Gynecol. 187 (2002) 434-440
31. Orange S.J., et al. Placental endothelial nitric oxide synthase localization and expression in normal human pregnancy and pre-eclampsia. Clin. Exp. Pharmacol. Physiol. 30 (2003) 376-381
32. Bachetti T., et al. Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. J. Mol. Cell. Cardiol. 37 (2004) 939-945
33. Zhou Y., et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?. J. Clin. Invest. 99 (1997) 2139-2151
34. Lyall F., et al. Human trophoblast invasion and spiral artery transformation: the role of nitric oxide. Am. J. Pathol. 154 (1999) 1105-1114
35. Martin D., and Conrad K.P. Expression of endothelial nitric oxide synthase by extravillous trophoblast cells in the human placenta. Placenta 21 (2000) 23-31
36. 2 subunit. J. Clin. Endocrinol. Metab. 86 (2001) 909-912
37. Sahin-Toth M., et al. Tetrahydrobiopterin preferentially stimulates activity and promotes subunit aggregation of membrane-bound calcium-dependent nitric oxide synthase in human placenta. Mol. Hum. Reprod. 3 (1997) 293-298
38. Podjarny E., et al. Animal models of preeclampsia. Semin. Perinatol. 23 (1999) 2-13
39. Lyall F. Development of the utero-placental circulation: the role of carbon monoxide and nitric oxide in trophoblast invasion and spiral artery transformation. Microsc. Res. Tech. 60 (2003) 402-411
40. Callejas N.A., et al. Requirement of nuclear factor κB for the constitutive expression of nitric oxide synthase-2 and cyclooxygenase-2 in rat trophoblasts. J. Cell Sci. 112 (1999) 3147-3155
41. Hambartsoumian E., et al. Differential expression and regulation of inducible nitric oxide synthase (iNOS) mRNA in human trophoblasts in vitro. Am. J. Reprod. Immunol. 45 (2001) 78-85
42. Dash P.R., et al. Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cyclic GMP-dependent mechanism and independently of caspase 3 nitrosylation. Exp. Cell Res. 287 (2003) 314-324
43. Rossmanith W.G., et al. Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta. Mol. Hum. Reprod. 5 (1999) 487-494
44. Kiss H., et al. Expression of endothelial (type III) nitric oxide synthase in cytotrophoblastic cell lines: regulation by hypoxia and inflammatory cytokines. Placenta 19 (1998) 603-611
45. Connelly L., et al. Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice: a pro-inflammatory role for eNOS-derived NO in vivo. J. Biol. Chem. 280 (2005) 10040-10046
46. Zimmermann K., et al. NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 17167-17172
47. Icking A., et al. NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS. J. Cell Sci. 118 (2005) 5059-5069
48. Toth M. Role of tetrahydrobiopterin in the regulation of activity of human placental nitric oxide synthase in normal and pre-eclamptic pregnancies. Orv. Hetil. 143 (2002) 391-398
49. Jansson T. Amino acid transporters in the human placenta. Pediatr. Res. 49 (2001) 141-147
50. Ayuk P.T., et al. Development and polarization of cationic amino acid transporters and regulators in the human placenta. Am. J. Physiol. Cell Physiol. 278 (2000) C1162-C1171
51. Noris M., et al. l-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 43 (2004) 614-622
52. Leiper J., and Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc. Res. 43 (1999) 542-548
53. Savvidou M.D., et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361 (2003) 1511-1517
54. Prior B.M., et al. Arteriogenesis: role of nitric oxide. Endothelium 10 (2003) 207-216
55. Cartwright J.E., et al. Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide. Br. J. Pharmacol. 128 (1999) 181-189
56. Novaro V., et al. Regulation of metalloproteinases by nitric oxide in human trophoblast cells in culture. Reprod. Fertil. Dev. 13 (2001) 411-420
57. Kaufmann P. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol. Reprod. 69 (2003) 1-7
58. Hemmings D.G., et al. Sphingosine-1-phosphate acts via Rho-associated kinase and nitric oxide to regulate human placental vascular tone. Biol. Reprod. 74 (2006) 88-94
59. Schonfelder G., et al. Preeclampsia is associated with loss of neuronal nitric oxide synthase expression in vascular smooth muscle cells of the human umbilical cord. Histopathology 44 (2004) 116-128
60. Tzao C., et al. Heterogeneous distribution of type I nitric oxide synthase in pulmonary vasculature of ovine fetus. Histochem. Cell Biol. 114 (2000) 421-430
61. Luzi G., et al. Nitric oxide donors in pregnancy: fetomaternal hemodynamic effects induced in mild pre-eclampsia and threatened preterm labor. Ultrasound Obstet. Gynecol. 14 (1999) 101-109
62. Sabry S., et al. In vitro contractile and relaxant responses of human resistance placental stem villi arteries of healthy parturients: role of endothelium. Fundam. Clin. Pharmacol. 9 (1995) 46-51
63. Leitch I.M., et al. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation. Clin. Exp. Pharmacol. Physiol. 21 (1994) 615-622
64. Acevedo C.G., et al. Insulin and nitric oxide stimulates glucose transport in human placenta. Life Sci. 76 (2005) 2643-2653
65. Sun K., et al. Differential regulation of 11 β-hydroxysteroid dehydrogenase type 1 and 2 by nitric oxide in cultured human placental trophoblast and chorionic cell preparation. Endocrinology 138 (1997) 4912-4920
66. Ni X., et al. Nitric oxide inhibits corticotropin-releasing hormone exocytosis but not synthesis by cultured human trophoblasts. J. Clin. Endocrinol. Metab. 82 (1997) 4171-4175
67. Rossmanith W.G., et al. Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta. Mol. Hum. Reprod. 5 (1999) 487-494
68. Makrigiannakis A., et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat. Immunol. 2 (2001) 1018-1024
69. Hillhouse E.W., and Grammatopoulos D.K. Role of stress peptides during human pregnancy and labour. Reproduction 124 (2002) 323-329
70. McLean M., et al. A placental clock controlling the length of human pregnancy. Nat. Med. 1 (1995) 460-463
71. Jones S.A., and Challis J.R. Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta. Biochem. Biophys. Res. Commun. 159 (1989) 192-199
72. Choy M.Y., et al. Corticotropin-releasing hormone peptide and human first-trimester placental growth. Early Hum. Dev. 79 (2004) 77-80
73. Bamberger A.M., et al. Corticotropin-releasing hormone modulates human trophoblast invasion through carcinoembryonic antigen-related cell adhesion molecule-1 regulation. Am. J. Pathol. 168 (2006) 141-150
74. Li W., and Challis J.R. Corticotrophin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in TIMP-1 by cultured cells from human placenta and fetal membranes. J. Clin. Endocrinol. Metab. 90 (2005) 6569-6574
75. Leitch I.M., et al. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J. Clin. Endocrinol. Metab. 83 (1998) 4510-4513
76. Karteris E., et al. Reduced expression of corticotropin-releasing hormone receptor type-1α in human preeclamptic and growth-restricted placentas. J. Clin. Endocrinol. Metab. 88 (2003) 363-370
77. Karteris E., et al. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. J. Clin. Endocrinol. Metab. 90 (2005) 3680-3687
78. Dong Y.L., et al. Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H230-H239
79. Napolitano M., et al. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J. Clin. Endocrinol. Metab. 85 (2000) 2318-2323
80. Li X., et al. Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J. Clin. Invest. 101 (1998) 442-454
81. Buhimschi I.A., et al. The nitric oxide pathway in pre-eclampsia: pathophysiological implications. Hum. Reprod. Update 4 (1998) 25-42
82. Rajagopal M., et al. Nitric oxide: does it have an etiological role in pre-eclampsia?. Acta Obstet. Gynecol. Scand. 82 (2003) 216-219
83. Shesely E.G., et al. Nitric oxide synthase gene knockout mice do not become hypertensive during pregnancy. Am. J. Obstet. Gynecol. 185 (2001) 1198-1203
84. Speake P.F., et al. l-Arginine transport across the basal plasma membrane of the syncytiotrophoblast of the human placenta from normal and preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 88 (2003) 4287-4292
85. Dong Y.L., et al. Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 90 (2005) 2336-2343
86. Donoghue J.F., et al. Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension. Placenta 21 (2000) 711-717
87. 1 in human preeclamptic placenta. Mol. Cell. Endocrinol. 184 (2001) 95-102
88. 1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7 (2001) 1003-1009
89. Wallukat G., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103 (1999) 945-952
90. Fiore G., et al. Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J. Clin. Endocrinol. Metab. 90 (2005) 4205-4210
91. Broglio F., et al. Endocrine and non-endocrine actions of ghrelin. Horm. Res. 59 (2003) 109-117
92. Caminos J.E., et al. Expression and regulation of adiponectin and receptor in human and rat placenta. J. Clin. Endocrinol. Metab. 90 (2005) 4276-4286
93. Chappell L.C., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354 (1999) 810-816
94. Downing J.W., et al. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia. Med. Hypotheses 63 (2004) 1057-1064
95. Rytlewski K., et al. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur. J. Clin. Invest. 35 (2005) 32-37